Aptose Biosciences Inc. (TSX:APS)
Canada · Delayed Price · Currency is CAD 2.260
+0.030 (1.35%)
Feb 9, 2026, 1:05 PM EST
Aptose Biosciences Market Cap
Aptose Biosciences has a market cap or net worth of CAD 5.77 million as of February 10, 2026. Its market cap has decreased by -69.08% in one year.
Market Cap
5.77M
Enterprise Value
31.40M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.26
Market Cap Chart
Since May 31, 1994, Aptose Biosciences's market cap has decreased from 47.29M to 5.77M, a decrease of -87.80%. That is a compound annual growth rate of -6.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 5.69M | 5.19% |
| Dec 31, 2025 | 5.41M | -72.33% |
| Dec 31, 2024 | 19.56M | -26.49% |
| Dec 29, 2023 | 26.61M | -63.04% |
| Dec 30, 2022 | 71.99M | -53.23% |
| Dec 31, 2021 | 153.93M | -69.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| COSCIENS Biopharma | 8.72M |
| Marvel Biosciences | 8.12M |
| Kane Biotech | 7.26M |
| BioVaxys Technology | 7.06M |
| PharmaTher Holdings | 6.83M |
| Quest PharmaTech | 6.77M |
| Restart Life Sciences | 5.94M |
| MYND Life Sciences | 5.22M |